SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artŪculo

CHUMNEY, Elinor C.  y  ROBINSON, Leslie C.. Efectos de las intervenciones del farmacéutico en pacientes polimedicados. Pharmacy Pract (Granada) [online]. 2006, vol.4, n.3, pp.103-109. ISSN 1885-642X.

    1. Zarowitz BJ, Stebelsky LA, Muma BK, Romain TM, Peterson EL. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy 2005;25(11):636-45. [ Links ]

    2. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States. The Slone Survey. JAMA 2002;287:337-44. [ Links ]

    3. Gurwitz JH, Field TS, Harrold LR. et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289(9):1107-16. [ Links ]

    4. Gomez ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Cur Opin Allergy Clin Immunol 2005;5:309-16. [ Links ]

    5. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001;30:205-11. [ Links ]

    6. Galt KA. Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs Medical Center. Pharmacotherapy 1998;18(5):1103-11. [ Links ]

    7. Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract 1995;41(5):469-72. [ Links ]

    8. Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother 2001;35(7-8):835-40. [ Links ]

    9. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996;100(4):428-37. [ Links ]

    10. Allard J, Hebert R, Rioux M, Asselin J, Voyer L. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ 2001;164(9):1291-6. [ Links ]

    11. Farrell VM, Hill VL, Hawkins JB, Newman LM, Learned RE Jr. Clinic for identifying and addressing polypharmacy. Am J Health Syst Pharm 2003; 60(18):1830-5. [ Links ]

    12. Lim WS, Low HN, Chan SP, Chen HN, Ding YY, Tan TL. Impact of a pharmacist consult clinic on a hospital-based geriatric outpatient clinic in Singapore. Ann Acad Med Singapore 2004;33(2):220-7. [ Links ]

    13. Hanlon JT, Landsman PB, Cowan K, et al. Physician agreement with pharmacist-suggested drug therapy changes for elderly outpatients. Am J Health Syst Pharm 1996;53:2735-7. [ Links ]

    14. Furniss L, Burns A, Craig SKL, Scobie S, Cooke J, Faragher B. Effects of a pharmacistís medication review in nursing homes. Br J Psychiatry 2000;176:563-7. [ Links ]

    15. Trygstad TK, Christensen D, Garmis J, Sullivan R, Wegner SE. Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: results from the North Carolina polypharmacy initiative. JMCP. 2005;11(7):575-83. [ Links ]

    16. Christensen D, Trygstad T, Sullivan R, Garmise J, Wegner SE. A Pharmacy management intervention for optimizing drug therapy for nursing home patients. Am J Geriatr Pharmacother. 2004;2(4):248-56. [ Links ]

    17. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;281(3):267-70. [ Links ]

    18. Doucette WR, McDonough RP, Klepser D, McCarthy R. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther 2005;27(7):1104-11. [ Links ]

    19. Schrader SL, Dressing B, Blue R, Jensen G, Miller D, Zawada ET. The medication reduction project: combating polypharmacy in South Dakota elders through community-based interventions. S D J Med. 1996;49(12):441-8. [ Links ]

    20. Shaughnessy, AF. Common drug interactions in the elderly. Emerg Med. 1992;24:21-31. [ Links ]

    21. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003;20(11):817-32. [ Links ]

    22. Garrett DG, Martin LA. The Asheville Project: participantsí perception of factors contributing to the success of a patient self-management diabetes program. J Am Pharm Assoc 2003;43(2):185-90. [ Links ]

    23. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Atlanta, GA: Division of Diabetes Translation, Centers for Disease Control and Prevention, US Dept of Health and Human Services; November 2005. [ Links ]

    24. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004; 27(suppl 2):B10-B21. [ Links ]

    25. Pogach LM, Hawley G, Weinstock R, et al. Diabetes prevalence and pharmacy use in the Veterans Health Administration (1994): use of an ambulatory care pharmacy-derived database. Diabetes Care 1998;21:368-373. [ Links ]

    26. Maciejewski ML, Maynard C. Diabetes-related utilization and costs for inpatient and outpatient services in the Veterans Administration. Diabetes Care 2004;27(suppl 2):B69-B73. [ Links ]

    27. Kerr E, Gerzoff RB, Krein SL, et al. Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med. 2004; 141:272-281. [ Links ]

    28. McBean AM, Jung K, and Virnig BA. Improved care and outcomes among elderly Medicare managed care beneficiaries with diabetes. Am J Manag Care 2005;11(4):213-22. [ Links ]